Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Partially Blinded Randomized Clinical Trial to Study the Immunogenicity and Safety of Intradermal Administration of ZOSTAVAX™ (V211)
Brief Summary: This study will compare the safety and immunogenicity of ZOSTAVAX™ (V211) administered both intradermally and subcutaneously at various doses.


Options:
A: Arm Label: HZ/su Lot A; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine (GSK 1437173A) | Arm Label: HZ/su Lot B; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine (GSK 1437173A) | Arm Label: HZ/su Lot C; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster vaccine (GSK 1437173A) | Intervention Type: BIOLOGICAL; Name: Herpes Zoster vaccine (GSK 1437173A); Assigned to Arm(s): HZ/su Lot A, HZ/su Lot B, HZ/su Lot C
B: Arm Label: Full Dose Subcutaneous; Type: ACTIVE_COMPARATOR; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Subcutaneous, Biological: Intradermal Placebo | Arm Label: 1/3 Dose Subcutaneous; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) 1/3 Dose Subcutaneous, Biological: Intradermal Placebo | Arm Label: Full Dose Intradermal; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Intradermal, Biological: Full Dose Intradermal Placebo | Arm Label: 1/3 Dose Intradermal; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal, Biological: Intradermal Placebo | Arm Label: 1/10 Dose Intradermal; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal, Biological: Intradermal Placebo | Arm Label: 1/27 Dose Intradermal; Type: EXPERIMENTAL; Interventions: Biological: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal, Biological: Intradermal Placebo | Intervention Type: BIOLOGICAL; Name: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Subcutaneous; Assigned to Arm(s): Full Dose Subcutaneous | Intervention Type: BIOLOGICAL; Name: ZOSTAVAX™ (Zoster Vaccine Live) 1/3 Dose Subcutaneous; Assigned to Arm(s): 1/3 Dose Subcutaneous | Intervention Type: BIOLOGICAL; Name: ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Intradermal; Assigned to Arm(s): Full Dose Intradermal | Intervention Type: BIOLOGICAL; Name: ZOSTAVAX™ (Zoster Vaccine Live) Partial Doses Intradermal; Assigned to Arm(s): 1/10 Dose Intradermal, 1/27 Dose Intradermal, 1/3 Dose Intradermal | Intervention Type: BIOLOGICAL; Name: Full Dose Intradermal Placebo; Assigned to Arm(s): Full Dose Intradermal | Intervention Type: BIOLOGICAL; Name: Intradermal Placebo; Assigned to Arm(s): 1/10 Dose Intradermal, 1/27 Dose Intradermal, 1/3 Dose Intradermal, 1/3 Dose Subcutaneous, Full Dose Subcutaneous
C: Arm Label: SC HZ/su Group; Type: EXPERIMENTAL; Interventions: Biological: Herpes zoster vaccine GSK1437173A | Arm Label: IM HZ/su Group; Type: ACTIVE_COMPARATOR; Interventions: Biological: Herpes zoster vaccine GSK1437173A | Intervention Type: BIOLOGICAL; Name: Herpes zoster vaccine GSK1437173A; Assigned to Arm(s): IM HZ/su Group, SC HZ/su Group
D: Arm Label: GSK1437173A group; Type: EXPERIMENTAL; Interventions: Biological: Herpes Zoster Vaccine GSK1437173A | Arm Label: Placebo group; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: Herpes Zoster Vaccine GSK1437173A; Assigned to Arm(s): GSK1437173A group | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo group

Answer: B